Retatrutide Dosage Calculator
Calculate the appropriate retatrutide dosage for weight loss based on your weight and treatment phase. This tool helps determine your current and target maintenance doses following clinical titration schedules.
How to Use This Calculator
- Enter your current weight in either kilograms or pounds
- Select your current treatment week (1-48)
- Choose your target maintenance dose based on your healthcare provider's recommendation
- Adjust the tolerance slider based on how well you tolerate the medication
Dosage Calculation Method
Current Dose = f(Week, Tolerance, Target Dose)
Dosing Schedule:
- Weeks 1-4: Starting dose (0.25-0.5 mg)
- Weeks 5-8: Dose escalation (1-2 mg)
- Weeks 9-16: Intermediate dose (4-8 mg)
- Weeks 17+: Maintenance dose (8-12 mg)
Example Calculation
Real-World Scenario:
A patient weighing 90 kg (198 lbs) is in week 12 of treatment with a target maintenance dose of 8 mg and good tolerance.
Given:
- Weight = 90 kg
- Treatment Week = 12
- Target Dose = 8 mg
- Tolerance = Good (2)
Calculation:
Based on the titration schedule, week 12 falls in the intermediate dose phase (weeks 9-16). With good tolerance, the patient can be escalated to 4 mg at this stage.
Result: Current dose = 4 mg weekly, with planned increase to 8 mg at week 17.
Why Proper Dosage Matters
Clinical Benefits
- Optimal weight loss results (15-24% in clinical trials)
- Reduced side effects through gradual titration
- Improved blood sugar control in diabetic patients
Safety Considerations
- Minimizes gastrointestinal side effects
- Reduces risk of hypoglycemia in diabetic patients
- Allows for individualized treatment plans
Common Mistakes & Tips
Frequently Asked Questions
References & Disclaimer
Medical Disclaimer
This calculator is for informational purposes only and does not constitute medical advice. The dosage recommendations provided are based on clinical trial data and general guidelines. Always consult with your healthcare provider before starting, adjusting, or discontinuing any medication. Your healthcare provider will determine the appropriate dosage based on your individual health status, medical history, and treatment response.
References
- Retatrutide for Obesity — Phase 2 Trial - New England Journal of Medicine, 2023
- Efficacy and safety of retatrutide in adults with obesity - Nature Medicine, 2023
- Retatrutide in Type 2 Diabetes: Phase 2 Trial - Diabetes, 2023
Accuracy Notice
This calculator provides estimates based on available clinical data. Individual results may vary. The actual dosage prescribed by your healthcare provider may differ based on factors not included in this calculator, such as kidney function, liver function, concurrent medications, and other health conditions.
About the Author
Kumaravel Madhavan
Web developer and data researcher creating accurate, easy-to-use calculators across health, finance, education, and construction and more. Works with subject-matter experts to ensure formulas meet trusted standards like WHO, NIH, and ISO.